Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.480
-0.018 (-3.66%)
Nov 21, 2024, 11:49 AM EST - Market open

Sensei Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
13.7518.6719.8115.827.534.09
Upgrade
Research & Development
18.6318.330.3821.6611.198.35
Upgrade
Operating Expenses
32.3836.9650.1937.4818.7112.44
Upgrade
Operating Income
-32.38-36.96-50.19-37.48-18.71-12.44
Upgrade
Interest Expense
-0.1-0.14-0.22-0.67-1.69-2.26
Upgrade
Interest & Investment Income
2.853.621.780.8--
Upgrade
Other Non Operating Income (Expenses)
-1.13-1.270.250.611-1.97
Upgrade
EBT Excluding Unusual Items
-30.76-34.76-48.37-36.75-19.41-16.67
Upgrade
Merger & Restructuring Charges
-0.1-0.1----
Upgrade
Gain (Loss) on Sale of Investments
1.061.06-0.22-0.62--
Upgrade
Gain (Loss) on Sale of Assets
--0.3----
Upgrade
Other Unusual Items
---0.570.05-0.08
Upgrade
Pretax Income
-29.8-34.1-48.59-36.79-20.1-16.74
Upgrade
Earnings From Continuing Operations
--34.1-48.59-36.79-20.1-16.74
Upgrade
Net Income
-29.8-34.1-48.59-36.79-20.1-16.74
Upgrade
Preferred Dividends & Other Adjustments
----0.13.8
Upgrade
Net Income to Common
-29.8-34.1-48.59-36.79-20.2-20.54
Upgrade
Shares Outstanding (Basic)
2528312820
Upgrade
Shares Outstanding (Diluted)
2528312820
Upgrade
Shares Change (YoY)
-14.70%-8.96%10.80%1618.88%338.85%0.02%
Upgrade
EPS (Basic)
-1.19-1.22-1.58-1.33-12.53-55.92
Upgrade
EPS (Diluted)
-1.19-1.22-1.58-1.33-12.53-55.92
Upgrade
Free Cash Flow
-25.19-32.2-39.35-32.29-18.91-8.62
Upgrade
Free Cash Flow Per Share
-1.00-1.15-1.28-1.17-11.73-23.48
Upgrade
EBITDA
-31.06-35.61-48.84-36.8-18.5-12.36
Upgrade
D&A For EBITDA
1.321.351.350.690.210.07
Upgrade
EBIT
-32.38-36.96-50.19-37.48-18.71-12.44
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.